Annual Shareholders Equity
-$2.48 M
-$6.88 M-156.43%
31 December 2023
Summary:
Yield10 Bioscience annual stockholders equity is currently -$2.48 million, with the most recent change of -$6.88 million (-156.43%) on 31 December 2023. During the last 3 years, it has fallen by -$12.02 million (-126.05%). YTEN annual shareholders equity is now -102.27% below its all-time high of $109.59 million, reached on 31 December 2006.YTEN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$6.24 M
-$2.92 M-88.29%
30 June 2024
Summary:
Yield10 Bioscience quarterly stockholders equity is currently -$6.24 million, with the most recent change of -$2.92 million (-88.29%) on 30 June 2024. Over the past year, it has dropped by -$6.63 million (-1691.33%). YTEN quarterly shareholders equity is now -105.69% below its all-time high of $109.59 million, reached on 31 December 2006.YTEN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -156.4% | -1691.3% |
3 y3 years | -126.0% | -133.7% |
5 y5 years | -143.6% | -338.1% |
YTEN Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -115.5% | at low | -133.7% | at low |
5 y | 5 years | -115.5% | +39.2% | -127.0% | at low |
alltime | all time | -102.3% | +94.7% | -105.7% | +88.4% |
Yield10 Bioscience Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | -$6.24 M(+88.3%) |
Mar 2024 | - | -$3.31 M(+33.4%) |
Dec 2023 | -$2.48 M(-156.4%) | -$2.48 M(-733.4%) |
Sept 2023 | - | $392.00 K(-33.2%) |
June 2023 | - | $587.00 K(-48.6%) |
Mar 2023 | - | $1.14 M(-74.0%) |
Dec 2022 | $4.40 M(-72.5%) | $4.40 M(-39.1%) |
Sept 2022 | - | $7.22 M(-29.7%) |
June 2022 | - | $10.27 M(-22.3%) |
Mar 2022 | - | $13.21 M(-17.6%) |
Dec 2021 | $16.03 M(+68.1%) | $16.03 M(-13.3%) |
Sept 2021 | - | $18.49 M(-9.6%) |
June 2021 | - | $20.46 M(-11.4%) |
Mar 2021 | - | $23.09 M(+142.3%) |
Dec 2020 | $9.53 M(-333.3%) | $9.53 M(-19.7%) |
Sept 2020 | - | $11.87 M(+39.9%) |
June 2020 | - | $8.49 M(-9.0%) |
Mar 2020 | - | $9.33 M(-328.4%) |
Dec 2019 | -$4.08 M(-171.7%) | -$4.08 M(-255.9%) |
Sept 2019 | - | $2.62 M(-41.2%) |
June 2019 | - | $4.45 M(-28.1%) |
Mar 2019 | - | $6.20 M(+8.7%) |
Dec 2018 | $5.70 M(-57.8%) | $5.70 M(-22.2%) |
Sept 2018 | - | $7.33 M(-23.5%) |
June 2018 | - | $9.58 M(-17.7%) |
Mar 2018 | - | $11.63 M(-13.8%) |
Dec 2017 | $13.50 M(+112.0%) | $13.50 M(+429.7%) |
Sept 2017 | - | $2.55 M(+13.7%) |
June 2017 | - | $2.24 M(-50.9%) |
Mar 2017 | - | $4.56 M(-28.4%) |
Dec 2016 | $6.37 M(-51.1%) | $6.37 M(-25.8%) |
Sept 2016 | - | $8.58 M(+107.1%) |
June 2016 | - | $4.14 M(-42.3%) |
Mar 2016 | - | $7.18 M(-44.9%) |
Dec 2015 | $13.03 M(-30.7%) | $13.03 M(-26.7%) |
Sept 2015 | - | $17.78 M(-22.6%) |
June 2015 | - | $22.96 M(+72.3%) |
Mar 2015 | - | $13.33 M(-29.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $18.80 M(-7.9%) | $18.80 M(-23.0%) |
Sept 2014 | - | $24.39 M(+255.4%) |
June 2014 | - | $6.86 M(-48.7%) |
Mar 2014 | - | $13.38 M(-34.4%) |
Dec 2013 | $20.40 M(-56.9%) | $20.40 M(-27.7%) |
Sept 2013 | - | $28.20 M(-18.5%) |
June 2013 | - | $34.60 M(-16.6%) |
Mar 2013 | - | $41.51 M(-12.3%) |
Dec 2012 | $47.34 M(+20.0%) | $47.34 M(-15.3%) |
Sept 2012 | - | $55.89 M(-10.8%) |
June 2012 | - | $62.67 M(-9.8%) |
Mar 2012 | - | $69.51 M(+76.1%) |
Dec 2011 | $39.46 M(+66.7%) | $39.46 M(-17.6%) |
Sept 2011 | - | $47.87 M(-14.8%) |
June 2011 | - | $56.19 M(+263.5%) |
Mar 2011 | - | $15.46 M(-34.7%) |
Dec 2010 | $23.68 M(-57.0%) | $23.68 M(-25.5%) |
Sept 2010 | - | $31.80 M(-21.4%) |
June 2010 | - | $40.44 M(-13.3%) |
Mar 2010 | - | $46.65 M(-15.2%) |
Dec 2009 | $55.04 M(-6.8%) | $55.04 M(+60.3%) |
Sept 2009 | - | $34.34 M(-19.2%) |
June 2009 | - | $42.51 M(-16.6%) |
Mar 2009 | - | $50.98 M(-13.7%) |
Dec 2008 | $59.09 M(-33.8%) | $59.09 M(-11.0%) |
Sept 2008 | - | $66.40 M(-11.2%) |
June 2008 | - | $74.80 M(-9.1%) |
Mar 2008 | - | $82.31 M(-7.7%) |
Dec 2007 | $89.20 M(-18.6%) | $89.20 M(-5.6%) |
Sept 2007 | - | $94.53 M(-6.1%) |
June 2007 | - | $100.63 M(-4.6%) |
Mar 2007 | - | $105.44 M(-3.8%) |
Dec 2006 | $109.59 M(-335.4%) | $109.59 M(-304.6%) |
Sept 2006 | - | -$53.57 M(+7.7%) |
June 2006 | - | -$49.76 M(+6.3%) |
Mar 2006 | - | -$46.79 M(+0.5%) |
Dec 2005 | -$46.56 M(+19.5%) | -$46.56 M(+19.5%) |
Dec 2004 | -$38.97 M(+35.4%) | -$38.97 M |
Dec 2002 | -$28.79 M | - |
FAQ
- What is Yield10 Bioscience annual stockholders equity?
- What is the all time high annual shareholders equity for Yield10 Bioscience?
- What is Yield10 Bioscience annual shareholders equity year-on-year change?
- What is Yield10 Bioscience quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly shareholders equity year-on-year change?
What is Yield10 Bioscience annual stockholders equity?
The current annual shareholders equity of YTEN is -$2.48 M
What is the all time high annual shareholders equity for Yield10 Bioscience?
Yield10 Bioscience all-time high annual stockholders equity is $109.59 M
What is Yield10 Bioscience annual shareholders equity year-on-year change?
Over the past year, YTEN annual stockholders equity has changed by -$6.88 M (-156.43%)
What is Yield10 Bioscience quarterly stockholders equity?
The current quarterly shareholders equity of YTEN is -$6.24 M
What is the all time high quarterly shareholders equity for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly stockholders equity is $109.59 M
What is Yield10 Bioscience quarterly shareholders equity year-on-year change?
Over the past year, YTEN quarterly stockholders equity has changed by -$6.63 M (-1691.33%)